Beth C. Seidenberg - Director at Sagimet Biosciences Inc.

Insider Transactions and Holdings

Entity Type
Individual
Role
Director
Stock Symbol
SGMT on Nasdaq
Industry
Pharmaceutical Preparations
All Insider Reports
All Insider Reports

There are no Buy or Sell transactions made by Beth C. Seidenberg since 8/17/2023

Holdings reported by Beth C. Seidenberg for Sagimet Biosciences Inc.

Class Num Shares Value Price $ Transaction Date Ownership Underlying Class Underlying Amount
Series A Common Stock 1.9M $7.79M $4.10 Jul 18, 2023 Indirect
Series A Common Stock 84.8K $348K $4.10 Jul 18, 2023 Direct
Series A Common Stock 46.9K $192K $4.10 Jul 18, 2023 By trust
Stock Option (Right to Buy) 51.5K Jun 5, 2024 Direct Series A Common Stock
Common Stock 0 Jul 18, 2023 Indirect
Series A Preferred Stock 0 Jul 18, 2023 Indirect Series A Common Stock
Series B-1 Preferred Stock 0 Jul 18, 2023 Indirect Series A Common Stock
Series B Preferred Stock 0 Jul 18, 2023 Indirect Series A Common Stock
Series C Preferred Stock 0 Jul 18, 2023 Indirect Series A Common Stock
Series D Preferred Stock 0 Jul 18, 2023 Indirect Series A Common Stock
Series E Preferred Stock 0 Jul 18, 2023 Direct Series A Common Stock
Series E Preferred Stock 0 Jul 18, 2023 Indirect Series A Common Stock
Series F Preferred Stock 0 Jul 18, 2023 Indirect Series A Common Stock

Transactions reported by Beth C. Seidenberg for Sagimet Biosciences Inc.

Sym Class Transaction % Value $ Price $ Shares Shares After Date Ownership